Amrize Ltd (NYSE:AMRZ) Stock Rated "Hold" by Sell-Side Analysts

Key Points

• Analysts hold a neutral view of Amrize: Twenty firms assign the stock a consensus “Hold” rating, with an average 12-month price target of $50.00 versus its recent price of $37.85.
• Recent analyst actions were mixed but generally cautious, including price-target cuts from JPMorgan and UBS, while Morgan Stanley maintained an “overweight” rating with a $63 target; Zacks downgraded the stock to “strong sell.”
• Amrize shares have declined significantly: The stock traded near its 52-week low of $35.78, well below its 52-week high of $65.94, after the company missed quarterly earnings estimates with adjusted EPS of $0.88 versus $0.92 expected.

Amrize Ltd (NYSE:AMRZ - Get Free Report) has earned a consensus recommendation of "Hold" from the twenty research firms that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $50.00.

Several equities analysts recently issued reports on the company. Longbow Research started coverage on Amrize in a research report on Monday, October 12th. They set a "buy" rating on the stock. JPMorgan Chase & Co. lowered their price objective on Amrize from $52.00 to $48.00 and set a "neutral" rating for the company in a research report on Tuesday. Morgan Stanley set a $63.00 price objective on Amrize and gave the company an "overweight" rating in a research note on Monday, June 22nd. Zacks Research cut shares of Amrize from a "hold" rating to a "strong sell" rating in a report on Wednesday, August 19th. Finally, UBS Group lowered their price target on shares of Amrize from $57.00 to $42.00 and set a "neutral" rating for the company in a report on Tuesday, September 22nd.

Insider Activity

In other Amrize news, CFO Baris Oran acquired 3,000 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were acquired at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the acquisition, the chief financial officer owned 3,000 shares in the company, valued at $142,140. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jacques Sanche purchased 4,150 shares of Amrize stock in a transaction dated Wednesday, August 26th. The shares were bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the completion of the acquisition, the director directly owned 9,766 shares of the company's stock, valued at approximately $439,665.32. This represents a 73.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have purchased 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is owned by company insiders.

Institutional Investors Weigh In On Amrize

Institutional investors and hedge funds have recently bought and sold shares of the business. Caldwell Sutter Capital Inc. grew its stake in Amrize by 11.5% during the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock valued at $150,000 after acquiring an additional 275 shares in the last quarter. Grove Bank & Trust increased its holdings in Amrize by 2.1% in the 3rd quarter. Grove Bank & Trust now owns 17,477 shares of the company's stock valued at $653,000 after acquiring an additional 353 shares during the last quarter. Mengis Capital Management Inc. lifted its stake in Amrize by 8.5% in the 4th quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company's stock worth $311,000 after purchasing an additional 450 shares in the last quarter. Norman Fields Gottscho Capital Management LLC lifted its stake in Amrize by 4.3% in the 2nd quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company's stock worth $614,000 after purchasing an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in Amrize by 3.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company's stock worth $542,000 after purchasing an additional 543 shares in the last quarter.

Amrize Trading Up 1.4%

Shares of NYSE:AMRZ traded up $0.54 on Friday, reaching $37.85. 4,542,880 shares of the company traded hands, compared to its average volume of 3,589,370. The stock has a market capitalization of $20.94 billion, a P/E ratio of 17.44, a price-to-earnings-growth ratio of 1.32 and a beta of 0.20. The business's 50-day simple moving average is $40.94 and its 200 day simple moving average is $48.83. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. Amrize has a 52 week low of $35.78 and a 52 week high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The company had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, equities analysts anticipate that Amrize will post 2.44 EPS for the current fiscal year.

Amrize Dividend Announcement

The firm also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were paid a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize's payout ratio is 5.07%.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.